首页 > 最新文献

Critical Care Research and Practice最新文献

英文 中文
Incidence and Impact of Ventilator Associated Multidrug Resistant Pneumonia in Patients with SARS-COV2. SARS-COV2患者呼吸机相关性多药耐药肺炎的发生率及影响
IF 1.7 Q3 CRITICAL CARE MEDICINE Pub Date : 2022-09-02 eCollection Date: 2022-01-01 DOI: 10.1155/2022/9730895
Seife Yohannes, Zaki Ahmed, Rachel Schelling, Swaminathan Perinkulam Sathyanarayanan, Alexandra Pratt, Mathew P Schreiber

Introduction: Ventilator Associated Pneumonia (VAP) is associated with significant cost, morbidity, and mortality. There is limited data on the incidence of VAP, appropriate antibiotic timing, and the impact of multidrug resistant VAP in intubated Coronavirus disease-19 (COVID-19) patients.

Methods: A retrospective study was conducted at 2 tertiary urban academic centers involving 132 COVID-19 patients requiring invasive mechanical ventilation (IMV). The epidemiology of VAP, the impact of prior empiric antibiotic administration on the development of Multidrug Resistant Organism (MDRO) infections, and the impact of VAP on patient outcomes were studied.

Results: The average age of the patients was 60.58% were males, 70% were African-Americans and two-thirds of patients had diabetes, hypertension, or heart disease. The average Body Mass Index (BMI) was 32.9. Forty-one patients (27%) developed VAP. Patients with VAP had a significantly higher Sequential Organ Failure Assessment (SOFA) score prior to Intensive Care Unit (ICU) admission. Sixty percent received empiric antibiotics before initiation of IMV, mostly on hospital admission, and 81% received empiric antibiotics at the time of intubation. The administration of empiric antibiotics was not associated with a higher prevalence of VAP. The prevalence of VAP was 22 per 1000 days on ventilation. No difference in mortality was seen between VAP and non-VAP groups at 49% and 57% respectively (p = 0.4). VAP was associated with increased ICU length of stay (LOS), 30 vs. 16 days (p < 0.001), and longer hospital LOS 35 vs. 17 days (p < 0.001). 40% of VAPs were caused by MDROs. The most common organism was Staphylococcus aureus (28%), with almost half (48%) being methicillin resistant Staphylococcus aureus (MRSA).

Conclusion: VAP was a common complication of patients intubated for COVID-19 pneumonia. Most patients received empiric antibiotics upon the hospital and/or ICU admission. There was a 40% incidence of multidrug resistant pneumonia. Patients who developed VAP had almost twice as long hospital and ICU LOS.

导论:呼吸机相关性肺炎(VAP)与显著的成本、发病率和死亡率相关。关于VAP的发生率、合适的抗生素时机以及多药耐药VAP对插管冠状病毒病-19 (COVID-19)患者的影响的数据有限。方法:对2个三级城市学术中心的132例需要有创机械通气(IMV)的COVID-19患者进行回顾性研究。研究了VAP的流行病学,既往经经验抗生素给药对多药耐药菌(MDRO)感染发展的影响,以及VAP对患者预后的影响。结果:患者平均年龄60.58%为男性,70%为非洲裔美国人,三分之二的患者患有糖尿病、高血压或心脏病。平均身体质量指数(BMI)为32.9。41例(27%)发生VAP。在重症监护病房(ICU)入院前,VAP患者的顺序器官衰竭评估(SOFA)评分明显较高。60%的患者在开始静脉注射前接受了经验性抗生素治疗,主要是在住院时,81%的患者在插管时接受了经验性抗生素治疗。经验性抗生素的使用与VAP的高患病率无关。通气时VAP发生率为22 / 1000 d。VAP组和非VAP组的死亡率无差异,分别为49%和57% (p = 0.4)。VAP与ICU住院时间(LOS)增加相关,分别为30天和16天(p < 0.001),住院时间(LOS)延长,分别为35天和17天(p < 0.001)。40%的VAPs是由mdro引起的。最常见的细菌是金黄色葡萄球菌(28%),几乎一半(48%)是耐甲氧西林金黄色葡萄球菌(MRSA)。结论:VAP是新型冠状病毒肺炎插管患者的常见并发症。大多数患者在入院和/或ICU时接受经验性抗生素治疗。耐多药肺炎的发生率为40%。发生VAP的患者在医院和ICU的LOS时间几乎是前者的两倍。
{"title":"Incidence and Impact of Ventilator Associated Multidrug Resistant Pneumonia in Patients with SARS-COV2.","authors":"Seife Yohannes,&nbsp;Zaki Ahmed,&nbsp;Rachel Schelling,&nbsp;Swaminathan Perinkulam Sathyanarayanan,&nbsp;Alexandra Pratt,&nbsp;Mathew P Schreiber","doi":"10.1155/2022/9730895","DOIUrl":"https://doi.org/10.1155/2022/9730895","url":null,"abstract":"<p><strong>Introduction: </strong>Ventilator Associated Pneumonia (VAP) is associated with significant cost, morbidity, and mortality. There is limited data on the incidence of VAP, appropriate antibiotic timing, and the impact of multidrug resistant VAP in intubated Coronavirus disease-19 (COVID-19) patients.</p><p><strong>Methods: </strong>A retrospective study was conducted at 2 tertiary urban academic centers involving 132 COVID-19 patients requiring invasive mechanical ventilation (IMV). The epidemiology of VAP, the impact of prior empiric antibiotic administration on the development of Multidrug Resistant Organism (MDRO) infections, and the impact of VAP on patient outcomes were studied.</p><p><strong>Results: </strong>The average age of the patients was 60.58% were males, 70% were African-Americans and two-thirds of patients had diabetes, hypertension, or heart disease. The average Body Mass Index (BMI) was 32.9. Forty-one patients (27%) developed VAP. Patients with VAP had a significantly higher Sequential Organ Failure Assessment (SOFA) score prior to Intensive Care Unit (ICU) admission. Sixty percent received empiric antibiotics before initiation of IMV, mostly on hospital admission, and 81% received empiric antibiotics at the time of intubation. The administration of empiric antibiotics was not associated with a higher prevalence of VAP. The prevalence of VAP was 22 per 1000 days on ventilation. No difference in mortality was seen between VAP and non-VAP groups at 49% and 57% respectively (<i>p</i> = 0.4). VAP was associated with increased ICU length of stay (LOS), 30 vs. 16 days (<i>p</i> < 0.001), and longer hospital LOS 35 vs. 17 days (<i>p</i> < 0.001). 40% of VAPs were caused by MDROs. The most common organism was <i>Staphylococcus aureus</i> (28%), with almost half (48%) being methicillin resistant <i>Staphylococcus aureus</i> (MRSA).</p><p><strong>Conclusion: </strong>VAP was a common complication of patients intubated for COVID-19 pneumonia. Most patients received empiric antibiotics upon the hospital and/or ICU admission. There was a 40% incidence of multidrug resistant pneumonia. Patients who developed VAP had almost twice as long hospital and ICU LOS.</p>","PeriodicalId":46583,"journal":{"name":"Critical Care Research and Practice","volume":" ","pages":"9730895"},"PeriodicalIF":1.7,"publicationDate":"2022-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463029/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33467163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Effect of Local Warm Compression on Restless Leg Syndrome and Fatigue among Critical Care Nurses: A Parallel Randomized Clinical Trial. 局部温压对重症护士不宁腿综合征和疲劳的影响:一项平行随机临床试验。
IF 1.7 Q3 CRITICAL CARE MEDICINE Pub Date : 2022-08-27 eCollection Date: 2022-01-01 DOI: 10.1155/2022/7330308
Maryam Ameri, Hossein Ebrahimi, Ahmad Khosravi, Seyedmohammad Mirhosseini, Mohammad Reza Khatibi

Methods and materials: This parallel randomized clinical trial was conducted on 120 CCNs in Shahroud by the census sampling method. Inclusion criteria included suffering from restless leg syndrome and having no wound or inflammation over the organ. The participants were assigned into two groups by the use of quadruple blocks. The intervention group received the warm compress for 12 sessions lasting 4 weeks and the control group did not receive an intervention. Data were collected using multidimensional fatigue inventory (MFI) and the Restless Legs Syndrome Scale and then analyzed using descriptive and inferential statistics (chi-squared test, independent sample t-test, and pair sample t-test).

Results: The two groups were homogeneous in terms of demographic characteristics. Prior to the intervention, the two groups of warm compression and control did not have a significant difference in terms of mean fatigue and restless leg syndrome scores; however, after the intervention, a significant reduction was observed in the intervention group (p < 0.001).

Conclusion: According to the results of the current study, the use of warm compression is an effective intervention in alleviating fatigue and restless leg syndrome, so it is recommended to implement this intervention as a nonpharmacological strategy among CCNs. Clinical Trial Registration Number. IRCT20190723044316N1.

方法与材料:采用人口普查抽样方法对沙赫鲁德地区120名ccn进行平行随机临床试验。纳入标准包括患有不宁腿综合征,没有伤口或器官炎症。参与者被分成两组,使用四组块。干预组接受热敷12次,持续4周,对照组不接受干预。采用多维疲劳量表(MFI)和不宁腿综合征量表收集数据,然后采用描述性统计和推理统计(卡方检验、独立样本t检验和成对样本t检验)进行分析。结果:两组在人口学特征上具有同质性。干预前,温压组和对照组两组在平均疲劳和不宁腿综合征评分方面无显著差异;然而,干预后,干预组观察到显著降低(p < 0.001)。结论:根据本研究结果,温压是缓解疲劳和不宁腿综合征的有效干预措施,建议在ccn中作为非药物策略实施温压干预。临床试验注册号。IRCT20190723044316N1。
{"title":"Effect of Local Warm Compression on Restless Leg Syndrome and Fatigue among Critical Care Nurses: A Parallel Randomized Clinical Trial.","authors":"Maryam Ameri,&nbsp;Hossein Ebrahimi,&nbsp;Ahmad Khosravi,&nbsp;Seyedmohammad Mirhosseini,&nbsp;Mohammad Reza Khatibi","doi":"10.1155/2022/7330308","DOIUrl":"https://doi.org/10.1155/2022/7330308","url":null,"abstract":"<p><strong>Methods and materials: </strong>This parallel randomized clinical trial was conducted on 120 CCNs in Shahroud by the census sampling method. Inclusion criteria included suffering from restless leg syndrome and having no wound or inflammation over the organ. The participants were assigned into two groups by the use of quadruple blocks. The intervention group received the warm compress for 12 sessions lasting 4 weeks and the control group did not receive an intervention. Data were collected using multidimensional fatigue inventory (MFI) and the Restless Legs Syndrome Scale and then analyzed using descriptive and inferential statistics (chi-squared test, independent sample <i>t</i>-test, and pair sample <i>t</i>-test).</p><p><strong>Results: </strong>The two groups were homogeneous in terms of demographic characteristics. Prior to the intervention, the two groups of warm compression and control did not have a significant difference in terms of mean fatigue and restless leg syndrome scores; however, after the intervention, a significant reduction was observed in the intervention group (<i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>According to the results of the current study, the use of warm compression is an effective intervention in alleviating fatigue and restless leg syndrome, so it is recommended to implement this intervention as a nonpharmacological strategy among CCNs. <i>Clinical Trial Registration Number</i>. IRCT20190723044316N1.</p>","PeriodicalId":46583,"journal":{"name":"Critical Care Research and Practice","volume":" ","pages":"7330308"},"PeriodicalIF":1.7,"publicationDate":"2022-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440832/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40353136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Readmission Following Perioperative Myocardial Injury: Clinical Predictors and Impact on Mortality. 围手术期心肌损伤后再入院:临床预测因素及其对死亡率的影响。
IF 1.7 Q3 CRITICAL CARE MEDICINE Pub Date : 2022-08-13 eCollection Date: 2022-01-01 DOI: 10.1155/2022/7674962
Alex Anzelmi, Yasser Khalil, Martin E Matsumura

Background: Perioperative myocardial injury (PMI) following noncardiac surgery is associated with a high risk for mortality, and readmission within 30 days of PMI increases this risk. Identifying risk factors for readmission among survivors of PMI is critical to improving outcomes in PMI. We examined risk factors for readmission following discharge after surgery complicated by PMI and the effect of readmission on 1-year mortality.

Methods: The study is a retropective cohort analysis of patients diagnosed with PMI in a single health system over a 10-year period. Univariate predictors of readmission were used to construct a multivariable logistic regression model. Mortality was assessed using Kaplan-Meyer survival analysis.

Results: Of the 207,729 surgical patients, 5159 (2.5%) had PMI. By 30 days following PMI, 1254 patients (24.3%) died, 1142 (22.2%) were readmitted but alive at 30 days, and 2763 patients (53.5%) were alive and had not been readmitted. Readmitted patients were older, had higher peak troponin levels, and were more likely to have prior coronary, neoplastic, lung, and kidney disease. Multivariable logistic regression revealed increasing age and peak troponin, prior cancer diagnosis, and chronic lung and kidney disease as independent predictors of readmission. Readmitted patients had higher 1-year mortality than those not readmitted (33.9% vs. 22.2%, p < 0.001).

Conclusions: Readmission following PMI is associated with increased mortality in the following year. Patients suffering from PMI who are at risk of readmission are older, have a greater extent of myocardial injury, and are more likely to have chronic comorbidities. Identification of patients at risk of readmission following PMI is critical to improving both outcomes and utilization of hospital resources.

背景:非心脏手术后围手术期心肌损伤(PMI)与高死亡率相关,PMI后30天内再入院增加了这一风险。确定PMI幸存者再入院的危险因素对改善PMI预后至关重要。我们检查了合并PMI的手术出院后再入院的危险因素以及再入院对1年死亡率的影响。方法:该研究是对在单一卫生系统中诊断为PMI的患者进行回顾性队列分析,为期10年。采用单变量再入院预测因子构建多变量logistic回归模型。使用Kaplan-Meyer生存分析评估死亡率。结果:在207,729例手术患者中,5159例(2.5%)有PMI。PMI后30天,1254例(24.3%)患者死亡,1142例(22.2%)患者再次入院,30天存活,2763例(53.5%)患者存活且未再次入院。再入院的患者年龄较大,肌钙蛋白峰值水平较高,既往有冠状动脉、肿瘤、肺部和肾脏疾病的可能性更大。多变量logistic回归显示,年龄增加、肌钙蛋白峰值、既往癌症诊断、慢性肺和肾脏疾病是再入院的独立预测因素。再入院患者的1年死亡率高于未再入院患者(33.9% vs. 22.2%, p < 0.001)。结论:PMI后再入院与次年死亡率增加相关。有再入院风险的PMI患者年龄较大,心肌损伤程度较大,并且更有可能患有慢性合并症。识别PMI后有再入院风险的患者对于改善预后和医院资源利用至关重要。
{"title":"Readmission Following Perioperative Myocardial Injury: Clinical Predictors and Impact on Mortality.","authors":"Alex Anzelmi,&nbsp;Yasser Khalil,&nbsp;Martin E Matsumura","doi":"10.1155/2022/7674962","DOIUrl":"https://doi.org/10.1155/2022/7674962","url":null,"abstract":"<p><strong>Background: </strong>Perioperative myocardial injury (PMI) following noncardiac surgery is associated with a high risk for mortality, and readmission within 30 days of PMI increases this risk. Identifying risk factors for readmission among survivors of PMI is critical to improving outcomes in PMI. We examined risk factors for readmission following discharge after surgery complicated by PMI and the effect of readmission on 1-year mortality.</p><p><strong>Methods: </strong>The study is a retropective cohort analysis of patients diagnosed with PMI in a single health system over a 10-year period. Univariate predictors of readmission were used to construct a multivariable logistic regression model. Mortality was assessed using Kaplan-Meyer survival analysis.</p><p><strong>Results: </strong>Of the 207,729 surgical patients, 5159 (2.5%) had PMI. By 30 days following PMI, 1254 patients (24.3%) died, 1142 (22.2%) were readmitted but alive at 30 days, and 2763 patients (53.5%) were alive and had not been readmitted. Readmitted patients were older, had higher peak troponin levels, and were more likely to have prior coronary, neoplastic, lung, and kidney disease. Multivariable logistic regression revealed increasing age and peak troponin, prior cancer diagnosis, and chronic lung and kidney disease as independent predictors of readmission. Readmitted patients had higher 1-year mortality than those not readmitted (33.9% vs. 22.2%, <i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>Readmission following PMI is associated with increased mortality in the following year. Patients suffering from PMI who are at risk of readmission are older, have a greater extent of myocardial injury, and are more likely to have chronic comorbidities. Identification of patients at risk of readmission following PMI is critical to improving both outcomes and utilization of hospital resources.</p>","PeriodicalId":46583,"journal":{"name":"Critical Care Research and Practice","volume":" ","pages":"7674962"},"PeriodicalIF":1.7,"publicationDate":"2022-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392591/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40632653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is the Critical Care Resuscitation Unit Sustainable: A 5-Year Experience of a Beneficial and Novel Model. 危重监护复苏单元是否可持续:一种有益的新模式的5年经验。
IF 1.7 Q3 CRITICAL CARE MEDICINE Pub Date : 2022-07-19 eCollection Date: 2022-01-01 DOI: 10.1155/2022/6171598
Elizabeth Powell, Iana Sahadzic, Daniel Najafali, Emilie Berman, Katie Andersen, Leenah Z Afridi, Zoe Gasparotti, Erin Niles, Jeffrey Rea, Thomas Scalea, Daniel J Haase, Quincy K Tran

Background: The 6-bed critical care resuscitation unit (CCRU) is a unique and specialized intensive care unit (ICU) that streamlines the interhospital transfer (IHT-transfer between different hospitals) process for a wide range of patients with critical illness or time-sensitive disease. Previous studies showed the unit successfully increased the number of ICU admissions while reducing the time of transfer in the first year of its establishment. However, its sustainability is unknown.

Methods: This was a descriptive retrospective analysis of adult, non-trauma patients who were transferred to an 800-bed quaternary medical center. Patients transferred to our medical center between January 1, 2014 and December 31, 2018 were eligible. We used interrupted time series (ITS) and descriptive analyses to describe the trend and compare the transfer process between patients who were transferred to the CCRU versus those transferred to other adult inpatient units.

Results: From 2014 to 2018, 50,599 patients were transferred to our medical center; 31,582 (62%) were non-trauma adults. Compared with the year prior to the opening of the CCRU, ITS showed a significant increase in IHT after the establishment of the CCRU. The CCRU received a total of 7,788 (25%) IHTs during this period or approximately 20% of total transfers per year. Most transfers (41%) occurred via ground. Median and interquartile range [IQR] of transfer times to other ICUs (156 [65-1027] minutes) were longer than the CCRU (46 [22-139] minutes, P < 0.001). For the CCRU, the most common accepting services were cardiac surgery (16%), neurosurgery (11%), and emergency general surgery (10%).

Conclusions: The CCRU increases the overall number of transfers to our institution, improves patient access to specialty care while decreasing transfer time, and continues to be a sustainable model over time. Additional research is needed to determine if transferring patients to the CCRU would continue to improve patients' outcomes and hospital revenue.

背景:6床重症监护复苏病房(CCRU)是一种独特的、专门的重症监护病房(ICU),它简化了各种危重疾病或时间敏感疾病患者的院际转移(不同医院之间的iht转移)过程。以前的研究表明,该单位在成立的第一年成功地增加了ICU入院人数,同时减少了转院时间。然而,它的可持续性是未知的。方法:这是一个描述性的回顾性分析,成人,非创伤患者转移到一个800床位的第四医疗中心。2014年1月1日至2018年12月31日转入我院的患者符合条件。我们使用中断时间序列(ITS)和描述性分析来描述趋势,并比较转到CCRU和转到其他成人住院单位的患者之间的转移过程。结果:2014 - 2018年,我院共转移患者50599例;31,582例(62%)为无创伤成人。与CCRU开通前一年相比,CCRU成立后ITS的IHT明显增加。在此期间,CCRU共接收了7,788次(25%)iht,约占每年总转移量的20%。大多数转移(41%)是通过地面进行的。转至其他icu的中位数和四分位间距[IQR] (156 [65 ~ 1027] min)均大于CCRU (46 [22 ~ 139] min, P < 0.001)。对于CCRU来说,最常见的接受服务是心脏外科(16%),神经外科(11%)和紧急普通外科(10%)。结论:CCRU增加了转到我们机构的总数量,改善了患者获得专业护理的机会,同时减少了转院时间,并且随着时间的推移继续成为一个可持续的模式。需要进一步的研究来确定将患者转移到CCRU是否会继续改善患者的预后和医院的收入。
{"title":"Is the Critical Care Resuscitation Unit Sustainable: A 5-Year Experience of a Beneficial and Novel Model.","authors":"Elizabeth Powell,&nbsp;Iana Sahadzic,&nbsp;Daniel Najafali,&nbsp;Emilie Berman,&nbsp;Katie Andersen,&nbsp;Leenah Z Afridi,&nbsp;Zoe Gasparotti,&nbsp;Erin Niles,&nbsp;Jeffrey Rea,&nbsp;Thomas Scalea,&nbsp;Daniel J Haase,&nbsp;Quincy K Tran","doi":"10.1155/2022/6171598","DOIUrl":"https://doi.org/10.1155/2022/6171598","url":null,"abstract":"<p><strong>Background: </strong>The 6-bed critical care resuscitation unit (CCRU) is a unique and specialized intensive care unit (ICU) that streamlines the interhospital transfer (IHT-transfer between different hospitals) process for a wide range of patients with critical illness or time-sensitive disease. Previous studies showed the unit successfully increased the number of ICU admissions while reducing the time of transfer in the first year of its establishment. However, its sustainability is unknown.</p><p><strong>Methods: </strong>This was a descriptive retrospective analysis of adult, non-trauma patients who were transferred to an 800-bed quaternary medical center. Patients transferred to our medical center between January 1, 2014 and December 31, 2018 were eligible. We used interrupted time series (ITS) and descriptive analyses to describe the trend and compare the transfer process between patients who were transferred to the CCRU versus those transferred to other adult inpatient units.</p><p><strong>Results: </strong>From 2014 to 2018, 50,599 patients were transferred to our medical center; 31,582 (62%) were non-trauma adults. Compared with the year prior to the opening of the CCRU, ITS showed a significant increase in IHT after the establishment of the CCRU. The CCRU received a total of 7,788 (25%) IHTs during this period or approximately 20% of total transfers per year. Most transfers (41%) occurred via ground. Median and interquartile range [IQR] of transfer times to other ICUs (156 [65-1027] minutes) were longer than the CCRU (46 [22-139] minutes, <i>P</i> < 0.001). For the CCRU, the most common accepting services were cardiac surgery (16%), neurosurgery (11%), and emergency general surgery (10%).</p><p><strong>Conclusions: </strong>The CCRU increases the overall number of transfers to our institution, improves patient access to specialty care while decreasing transfer time, and continues to be a sustainable model over time. Additional research is needed to determine if transferring patients to the CCRU would continue to improve patients' outcomes and hospital revenue.</p>","PeriodicalId":46583,"journal":{"name":"Critical Care Research and Practice","volume":" ","pages":"6171598"},"PeriodicalIF":1.7,"publicationDate":"2022-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325651/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40660775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Patient Perception of Informed Consent and Its Associated Factors among Surgical Patients Attending Public Hospitals in Dessie City Administration, Northeast Ethiopia. 埃塞俄比亚东北部德西市政府公立医院外科患者知情同意的感知及其相关因素
IF 1.7 Q3 CRITICAL CARE MEDICINE Pub Date : 2022-07-01 eCollection Date: 2022-01-01 DOI: 10.1155/2022/6269921
Hana Gebrehiwot, Nathan Estifanos, Yosef Zenebe, Tamrat Anbesaw

Background: Poor perception of informed consent compromises patients' autonomy and self-determination; as a result, they feel powerless and unaccountable for their treatment. This study aimed to assess patients' perception of informed consent and its associated factors among surgical patients attending public hospitals in Dessie City Administration, Northeast Ethiopia.

Methods: Facility-based cross-sectional study was conducted on 422 surgical patients. A systematic sampling technique was used to select the study participants. Data were collected using a pretested structured interviewer-administered questionnaire. EpiData version 3.1 was used for data entry, and then data were exported to SPSS version 25 for analysis. Multivariable logistic regression analysis was done to identify factors associated with the outcome variable among the participants. Variables with p value less than 0.05 were considered statistically significant factors.

Results: The prevalence of poor perception of informed consent for surgical procedures was found to be 33.2% (95% CI: 28.8-37.8). In multivariable analysis, educational status with inability to read and write (AOR = 5.71; 95% CI: 2.76-11.80) and basic ability to read and write (AOR = 6.03; 95% CI: 2.57-14.16), rural residence (AOR = 3.71; 95% CI: 1.94-7.07), marital status being widowed and divorced (AOR = 3.85; 95% CI: 1.83-8.08), language of written informed consent different from mother tongue (AOR = 4.196; 95% CI: 1.12-15.78), poor patient-physician relationship (AOR = 2.35; 95% CI: 1.31-4.24), and poor knowledge of surgical informed consent (AOR = 3.05; 95% CI: 1.56-5.97) were significantly associated with poor perception of surgical informed consent.

Conclusion: In this study, one-third of surgical patients appear to have poor perceptions of informed consent for surgical procedures. Educational status, being rural residents, being widowed/divorced, language of written informed consent, poor patient-physician relationship, and poor knowledge of surgical informed consent were variables that are independent predictors of poor perception of informed consent for surgical procedures. The ministry of health and healthcare providers should develop a plan to raise patients' awareness about the informed consent process for surgical procedures.

背景:对知情同意的不良认知损害了患者的自主权和自决权;结果,他们感到无能为力,对自己的待遇不负责任。本研究旨在评估埃塞俄比亚东北部德西市政府公立医院外科患者对知情同意的认知及其相关因素。方法:对422例外科手术患者进行横断面研究。采用系统抽样技术选择研究对象。数据收集使用预先测试的结构化访谈者管理问卷。使用EpiData 3.1版本进行数据录入,然后导出到SPSS 25版本进行分析。进行多变量logistic回归分析,以确定参与者中与结果变量相关的因素。p值小于0.05的变量被认为是有统计学意义的因素。结果:对手术知情同意认知不良的患病率为33.2% (95% CI: 28.8-37.8)。多变量分析中,无读写能力的学历(AOR = 5.71;95% CI: 2.76-11.80)和基本读写能力(AOR = 6.03;95% CI: 2.57-14.16),农村居民(AOR = 3.71;95% CI: 1.94-7.07),婚姻状况丧偶和离婚(AOR = 3.85;95% CI: 1.83-8.08),书面知情同意书的语言与母语不同(AOR = 4.196;95% CI: 1.12-15.78),医患关系差(AOR = 2.35;95% CI: 1.31-4.24),以及手术知情同意知识贫乏(AOR = 3.05;95% CI: 1.56-5.97)与手术知情同意认知不良显著相关。结论:在这项研究中,三分之一的手术患者似乎对手术过程的知情同意有很差的认识。教育状况、农村居民、丧偶/离婚、书面知情同意的语言、不良的医患关系以及对手术知情同意的不了解是对手术知情同意认知不良的独立预测变量。卫生部和医疗保健提供者应制定一项计划,提高患者对外科手术知情同意程序的认识。
{"title":"Patient Perception of Informed Consent and Its Associated Factors among Surgical Patients Attending Public Hospitals in Dessie City Administration, Northeast Ethiopia.","authors":"Hana Gebrehiwot,&nbsp;Nathan Estifanos,&nbsp;Yosef Zenebe,&nbsp;Tamrat Anbesaw","doi":"10.1155/2022/6269921","DOIUrl":"https://doi.org/10.1155/2022/6269921","url":null,"abstract":"<p><strong>Background: </strong>Poor perception of informed consent compromises patients' autonomy and self-determination; as a result, they feel powerless and unaccountable for their treatment. This study aimed to assess patients' perception of informed consent and its associated factors among surgical patients attending public hospitals in Dessie City Administration, Northeast Ethiopia.</p><p><strong>Methods: </strong>Facility-based cross-sectional study was conducted on 422 surgical patients. A systematic sampling technique was used to select the study participants. Data were collected using a pretested structured interviewer-administered questionnaire. EpiData version 3.1 was used for data entry, and then data were exported to SPSS version 25 for analysis. Multivariable logistic regression analysis was done to identify factors associated with the outcome variable among the participants. Variables with <i>p</i> value less than 0.05 were considered statistically significant factors.</p><p><strong>Results: </strong>The prevalence of poor perception of informed consent for surgical procedures was found to be 33.2% (95% CI: 28.8-37.8). In multivariable analysis, educational status with inability to read and write (AOR = 5.71; 95% CI: 2.76-11.80) and basic ability to read and write (AOR = 6.03; 95% CI: 2.57-14.16), rural residence (AOR = 3.71; 95% CI: 1.94-7.07), marital status being widowed and divorced (AOR = 3.85; 95% CI: 1.83-8.08), language of written informed consent different from mother tongue (AOR = 4.196; 95% CI: 1.12-15.78), poor patient-physician relationship (AOR = 2.35; 95% CI: 1.31-4.24), and poor knowledge of surgical informed consent (AOR = 3.05; 95% CI: 1.56-5.97) were significantly associated with poor perception of surgical informed consent.</p><p><strong>Conclusion: </strong>In this study, one-third of surgical patients appear to have poor perceptions of informed consent for surgical procedures. Educational status, being rural residents, being widowed/divorced, language of written informed consent, poor patient-physician relationship, and poor knowledge of surgical informed consent were variables that are independent predictors of poor perception of informed consent for surgical procedures. The ministry of health and healthcare providers should develop a plan to raise patients' awareness about the informed consent process for surgical procedures.</p>","PeriodicalId":46583,"journal":{"name":"Critical Care Research and Practice","volume":" ","pages":"6269921"},"PeriodicalIF":1.7,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270118/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40604764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Positive and Negative Effects of Calcium Supplementation on Mortality in Septic ICU Patients Depend on Disease Severity: A Retrospective Study from the MIMIC-III. 补钙对脓毒症ICU患者死亡率的正负影响取决于疾病严重程度:来自MIMIC-III的回顾性研究
IF 1.7 Q3 CRITICAL CARE MEDICINE Pub Date : 2022-06-22 eCollection Date: 2022-01-01 DOI: 10.1155/2022/2520695
Wencheng He, Lei Huang, Hua Luo, Jingying Chen, Weijia Li, Yiming Zhang, Youzhong An, Weixing Zhang

Background: Calcium administration in septic patients with hypocalcemia is a controversial issue. The present study preliminarily investigated the effects of calcium supplementation on the length of hospitalization and mortality in septic ICU patients with different severities of hypocalcemia and disease.

Method: A total of 5761 eligible septic patients, including 2689 who received calcium supplementation and 3072 who did not receive calcium supplementation, were extracted from the Medical Information Mart for Intensive Care III (MIMIC-III) database. The cofounding covariates between the calcium supplement and nonsupplement groups were balanced using the propensity score matching model. We compared the length of stay (LOS) in the ICU and hospital with 28-day and hospital mortality and stratified the analysis according to the sequential organ failure assessment (SOFA) score and ionized calcium (iCa) at the first ICU admission in the matched groups.

Results: The results showed that iCa at the first ICU admission was associated with mortality in sepsis patients (HR: 0.421; 95% CI: 0.211∼0.837), but the lowest mortality rate was observed in patients with mild hypocalcemia. A total of 993 paired patients were included in the analysis after propensity score matching. Regardless of the SOFA score or presence of iCa, the LOS in the ICU was higher in the calcium supplement group than in the nonsupplement group. The survival analysis was stratified by the SOFA score and showed that calcium supplementation reduced mortality when the patient's SOFA score was ≥8 (p=0.002), and it worsened the outcome when the patient's SOFA score was ≤4 (p=0.010). It had no significant effect on patients with SOFA scores ranging from 5 to 7 (p=0.911).

Conclusion: Our results showed that mild hypocalcemia may be protective in septic patients, and calcium supplementation may have positive and negative effects on mortality depending on disease severity. The SOFA score may be a valuable clinical index for decisions regarding calcium administration.

背景:脓毒症低钙患者的钙给药是一个有争议的问题。本研究初步探讨了补钙对脓毒症ICU不同严重程度低钙血症及疾病患者住院时间及死亡率的影响。方法:从重症监护医学信息市场III (MIMIC-III)数据库中提取5761例符合条件的脓毒症患者,其中补钙组2689例,未补钙组3072例。使用倾向评分匹配模型平衡补钙组和非补钙组之间的协变量。我们比较了两组患者在ICU和医院的住院时间(LOS)(28天)和住院死亡率,并根据匹配组首次入住ICU时的顺序器官衰竭评估(SOFA)评分和电离钙(iCa)进行分层分析。结果:脓毒症患者首次入住ICU时的iCa与死亡率相关(HR: 0.421;95% CI: 0.211 ~ 0.837),但在轻度低钙血症患者中观察到最低的死亡率。倾向评分匹配后,共纳入993例配对患者。无论SOFA评分或是否存在iCa,补钙组ICU的LOS高于未补钙组。根据SOFA评分对生存分析进行分层,结果显示,当患者的SOFA评分≥8分时,补钙降低了死亡率(p=0.002),当患者的SOFA评分≤4分时,补钙使预后恶化(p=0.010)。对SOFA评分在5 ~ 7分的患者无显著影响(p=0.911)。结论:我们的研究结果表明,轻度低钙血症可能对脓毒症患者有保护作用,补钙可能对死亡率有积极和消极的影响,这取决于疾病的严重程度。SOFA评分可能是决定钙给药的一个有价值的临床指标。
{"title":"The Positive and Negative Effects of Calcium Supplementation on Mortality in Septic ICU Patients Depend on Disease Severity: A Retrospective Study from the MIMIC-III.","authors":"Wencheng He,&nbsp;Lei Huang,&nbsp;Hua Luo,&nbsp;Jingying Chen,&nbsp;Weijia Li,&nbsp;Yiming Zhang,&nbsp;Youzhong An,&nbsp;Weixing Zhang","doi":"10.1155/2022/2520695","DOIUrl":"https://doi.org/10.1155/2022/2520695","url":null,"abstract":"<p><strong>Background: </strong>Calcium administration in septic patients with hypocalcemia is a controversial issue. The present study preliminarily investigated the effects of calcium supplementation on the length of hospitalization and mortality in septic ICU patients with different severities of hypocalcemia and disease.</p><p><strong>Method: </strong>A total of 5761 eligible septic patients, including 2689 who received calcium supplementation and 3072 who did not receive calcium supplementation, were extracted from the Medical Information Mart for Intensive Care III (MIMIC-III) database. The cofounding covariates between the calcium supplement and nonsupplement groups were balanced using the propensity score matching model. We compared the length of stay (LOS) in the ICU and hospital with 28-day and hospital mortality and stratified the analysis according to the sequential organ failure assessment (SOFA) score and ionized calcium (iCa) at the first ICU admission in the matched groups.</p><p><strong>Results: </strong>The results showed that iCa at the first ICU admission was associated with mortality in sepsis patients (HR: 0.421; 95% CI: 0.211∼0.837), but the lowest mortality rate was observed in patients with mild hypocalcemia. A total of 993 paired patients were included in the analysis after propensity score matching. Regardless of the SOFA score or presence of iCa, the LOS in the ICU was higher in the calcium supplement group than in the nonsupplement group. The survival analysis was stratified by the SOFA score and showed that calcium supplementation reduced mortality when the patient's SOFA score was ≥8 (<i>p</i>=0.002), and it worsened the outcome when the patient's SOFA score was ≤4 (<i>p</i>=0.010). It had no significant effect on patients with SOFA scores ranging from 5 to 7 (<i>p</i>=0.911).</p><p><strong>Conclusion: </strong>Our results showed that mild hypocalcemia may be protective in septic patients, and calcium supplementation may have positive and negative effects on mortality depending on disease severity. The SOFA score may be a valuable clinical index for decisions regarding calcium administration.</p>","PeriodicalId":46583,"journal":{"name":"Critical Care Research and Practice","volume":" ","pages":"2520695"},"PeriodicalIF":1.7,"publicationDate":"2022-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242801/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40556898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
The Feasibility of Percutaneous Dilatational Tracheostomy in Immunosuppressed ICU Patients with or without Thrombocytopenia 经皮扩张气管造口术治疗免疫抑制型ICU伴或不伴血小板减少症患者的可行性
IF 1.7 Q3 CRITICAL CARE MEDICINE Pub Date : 2022-05-26 DOI: 10.1155/2022/5356413
Marianne Angelberger, M. Barnikel, A. Fraccaroli, J. Tischer, Sofía Antón, Alexandra Pawlikowski, M. op den Winkel, H. Stemmler, Stephanie-Susanne Stecher
Background Percutaneous dilatational tracheostomy (PDT) has become the preferred method in several intensive care units (ICUs), but data on PDT performed in immunosuppressed and thrombocytopenic patients are scarce. This study aimed to analyze the feasibility of PDT in immunosuppressed and thrombocytopenic patients compared to conventional open surgical tracheostomy (OST). Methods We retrospectively analyzed the charts of patients who underwent PDT or OST between May 2017 and November 2020. Our outcomes were stoma site infections and bleeding complications. Results 63 patients underwent PDT, and 21 patients underwent OST. Distribution of gender ratio, age, SAPS II, time of ventilation before tracheostomy, and preexisting hematooncological diseases was comparable between the two groups. After allogeneic stem cell transplantation (alloSCT), patients were more likely to undergo PDT than OST (p=0.033). The PDT cohort suffered from mucositis more frequently (p=0.043). There were no significant differences in leucocyte or platelet count on the tracheostomy day. Patients with coagulation disorders and patients under immunosuppression were distributed equally among both groups. Stoma site infection was documented in five cases in PDT and eight cases in the OST group. Moderate infections were remarkably increased in the OST group. Smears were positive in six cases in the PDT group; none of these patients had local infection signs. In the OST group, smears were positive in four cases; all had signs of a stroma site infection. Postprocedural bleedings occurred in eight cases (9.5%) and were observed significantly more often in the OST group (p=0.001), leading to emergency surgery in one case of the OST group. Conclusion PDT is a feasible and safe procedure in a predominantly immunosuppressed and thrombocytopenic patient cohort without an increased risk for stoma site infections or bleeding complications.
经皮扩张性气管造口术(PDT)已成为一些重症监护病房(icu)的首选方法,但在免疫抑制和血小板减少患者中进行PDT的数据很少。本研究旨在分析PDT在免疫抑制和血小板减少患者中的可行性,并与传统的开放手术气管切开术(OST)进行比较。方法回顾性分析2017年5月至2020年11月期间接受PDT或OST的患者图表。我们的结果是造口部位感染和出血并发症。结果63例患者行PDT, 21例患者行OST。两组患者的性别比例、年龄、SAPS、气管造口术前通气时间和既往存在的血液肿瘤疾病分布具有可比性。同种异体干细胞移植(alloSCT)后,患者发生PDT的可能性高于OST (p=0.033)。PDT组出现粘膜炎的频率更高(p=0.043)。两组患者在气管切开术当日白细胞和血小板计数无明显差异。凝血功能障碍患者和免疫抑制患者在两组中平均分布。PDT组有5例造口部位感染,OST组有8例。OST组的中度感染明显增加。PDT组6例涂片阳性;这些患者均无局部感染征象。在OST组中,4例涂片阳性;都有间质感染的迹象。8例(9.5%)发生术后出血,OST组出血发生率明显高于OST组(p=0.001),导致OST组1例急诊手术。结论PDT在免疫抑制和血小板减少患者中是一种可行且安全的手术,不会增加造口部位感染或出血并发症的风险。
{"title":"The Feasibility of Percutaneous Dilatational Tracheostomy in Immunosuppressed ICU Patients with or without Thrombocytopenia","authors":"Marianne Angelberger, M. Barnikel, A. Fraccaroli, J. Tischer, Sofía Antón, Alexandra Pawlikowski, M. op den Winkel, H. Stemmler, Stephanie-Susanne Stecher","doi":"10.1155/2022/5356413","DOIUrl":"https://doi.org/10.1155/2022/5356413","url":null,"abstract":"Background Percutaneous dilatational tracheostomy (PDT) has become the preferred method in several intensive care units (ICUs), but data on PDT performed in immunosuppressed and thrombocytopenic patients are scarce. This study aimed to analyze the feasibility of PDT in immunosuppressed and thrombocytopenic patients compared to conventional open surgical tracheostomy (OST). Methods We retrospectively analyzed the charts of patients who underwent PDT or OST between May 2017 and November 2020. Our outcomes were stoma site infections and bleeding complications. Results 63 patients underwent PDT, and 21 patients underwent OST. Distribution of gender ratio, age, SAPS II, time of ventilation before tracheostomy, and preexisting hematooncological diseases was comparable between the two groups. After allogeneic stem cell transplantation (alloSCT), patients were more likely to undergo PDT than OST (p=0.033). The PDT cohort suffered from mucositis more frequently (p=0.043). There were no significant differences in leucocyte or platelet count on the tracheostomy day. Patients with coagulation disorders and patients under immunosuppression were distributed equally among both groups. Stoma site infection was documented in five cases in PDT and eight cases in the OST group. Moderate infections were remarkably increased in the OST group. Smears were positive in six cases in the PDT group; none of these patients had local infection signs. In the OST group, smears were positive in four cases; all had signs of a stroma site infection. Postprocedural bleedings occurred in eight cases (9.5%) and were observed significantly more often in the OST group (p=0.001), leading to emergency surgery in one case of the OST group. Conclusion PDT is a feasible and safe procedure in a predominantly immunosuppressed and thrombocytopenic patient cohort without an increased risk for stoma site infections or bleeding complications.","PeriodicalId":46583,"journal":{"name":"Critical Care Research and Practice","volume":" ","pages":""},"PeriodicalIF":1.7,"publicationDate":"2022-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48127713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Validity of Quantifying Pulmonary Contusion Extent by Lung Ultrasound Score for Predicting ARDS in Blunt Thoracic Trauma 肺超声评分定量肺挫伤程度预测钝性胸外伤ARDS的有效性
IF 1.7 Q3 CRITICAL CARE MEDICINE Pub Date : 2022-05-24 DOI: 10.1155/2022/3124966
M. Sayed, Kareem Abdelhamid Elmeslmany, Ahmed Samir Elsawy, N. Mohamed
Background Thoracic trauma comprises 20–25% of all traumas worldwide and constitutes the third most common cause of death after abdominal injury and head trauma in polytrauma patients. Pulmonary contusion (PC) is a common injury seen after blunt trauma that is associated with significant morbidity and mortality. The aim of this prospective study was to determine the value of PC extent measurements using lung ultrasound in predicting high risk patients for ARDS development. Methods In one year, 50 polytrauma patients with blunt chest trauma were admitted to the ICU at Damanhur Institute. Lung contusion extent was evaluated using a lung US score (LUS) and was compared to the CT contusion score. The ability of the LUS to predict ARDS was tested. The diagnostic accuracy of LUS was compared with chest radiography for lung contusion and pneumothorax with thoracic CT scan as a reference. Patients were restratified by LUS into two groups: severe and nonsevere contusion group. The two groups' data were compared with respect to difference in mortality and injury characteristics. Results Lung contusion assessed by LUS score was well correlated to thoracic CT scan measurements (r = 0.78). A LUS of 4 was defined as a cut-off value for predicting ARDS development within 72 hours of trauma with sensitivity and specificity (91.67% and 84.21%), respectively. Patients with severe lung contusions had a lower hypoxic index on admission, more ventilator days, a higher risk of ARDS development, more fractured ribs; higher rate of hemothorax and a higher ISS score than patients with nonsevere lung contusions. Conclusion LUS on admission can quantify lung contusion extent and the high risk of developing ARDS after blunt thoracic trauma.
背景胸部创伤占全球所有创伤的20-25%,是多发性创伤患者中仅次于腹部损伤和头部创伤的第三大常见死亡原因。肺挫伤(PC)是钝性创伤后常见的损伤,与严重的发病率和死亡率有关。这项前瞻性研究的目的是确定使用肺部超声测量PC范围在预测ARDS发展的高危患者中的价值。方法一年内收治50例胸部钝性创伤多发伤患者入住达曼呼研究所ICU。使用肺US评分(LUS)评估肺挫伤程度,并与CT挫伤评分进行比较。对LUS预测ARDS的能力进行了测试。以胸部CT扫描为参考,比较LUS与胸部x线片对肺挫伤和肺气肿的诊断准确性。LUS将患者分为两组:严重挫伤组和非严重挫伤组。比较两组的数据在死亡率和损伤特征方面的差异。结果肺挫伤LUS评分与胸部CT扫描结果有良好相关性(r = 4的LUS被定义为预测创伤后72小时内ARDS发展的临界值,其敏感性和特异性分别为91.67%和84.21%。严重肺挫伤患者入院时缺氧指数较低,呼吸机天数较多,ARDS发生风险较高,肋骨骨折较多;血胸发生率和ISS评分高于非严重肺挫伤患者。结论LUS可定量分析胸部钝性创伤后肺挫伤程度及ARDS的高危程度。
{"title":"The Validity of Quantifying Pulmonary Contusion Extent by Lung Ultrasound Score for Predicting ARDS in Blunt Thoracic Trauma","authors":"M. Sayed, Kareem Abdelhamid Elmeslmany, Ahmed Samir Elsawy, N. Mohamed","doi":"10.1155/2022/3124966","DOIUrl":"https://doi.org/10.1155/2022/3124966","url":null,"abstract":"Background Thoracic trauma comprises 20–25% of all traumas worldwide and constitutes the third most common cause of death after abdominal injury and head trauma in polytrauma patients. Pulmonary contusion (PC) is a common injury seen after blunt trauma that is associated with significant morbidity and mortality. The aim of this prospective study was to determine the value of PC extent measurements using lung ultrasound in predicting high risk patients for ARDS development. Methods In one year, 50 polytrauma patients with blunt chest trauma were admitted to the ICU at Damanhur Institute. Lung contusion extent was evaluated using a lung US score (LUS) and was compared to the CT contusion score. The ability of the LUS to predict ARDS was tested. The diagnostic accuracy of LUS was compared with chest radiography for lung contusion and pneumothorax with thoracic CT scan as a reference. Patients were restratified by LUS into two groups: severe and nonsevere contusion group. The two groups' data were compared with respect to difference in mortality and injury characteristics. Results Lung contusion assessed by LUS score was well correlated to thoracic CT scan measurements (r = 0.78). A LUS of 4 was defined as a cut-off value for predicting ARDS development within 72 hours of trauma with sensitivity and specificity (91.67% and 84.21%), respectively. Patients with severe lung contusions had a lower hypoxic index on admission, more ventilator days, a higher risk of ARDS development, more fractured ribs; higher rate of hemothorax and a higher ISS score than patients with nonsevere lung contusions. Conclusion LUS on admission can quantify lung contusion extent and the high risk of developing ARDS after blunt thoracic trauma.","PeriodicalId":46583,"journal":{"name":"Critical Care Research and Practice","volume":"2022 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2022-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41543227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Ketamine Boluses Are Associated with a Reduction in Intracranial Pressure and an Increase in Cerebral Perfusion Pressure: A Retrospective Observational Study of Patients with Severe Traumatic Brain Injury 氯胺酮丸与颅内压降低和脑灌注压升高有关:重型颅脑损伤患者的回顾性观察研究
IF 1.7 Q3 CRITICAL CARE MEDICINE Pub Date : 2022-05-21 DOI: 10.1155/2022/3834165
Bradley A Dengler, O. Karam, Colleen A Barthol, Aaron B. Chance, Laura E. Snider, Clare M. Mundy, M. Bounajem, W. C. Johnson, M. Maita, Paola M. Mendez-Gomez, A. Seifi, Shaheryar Hafeez
Background Increased intracranial pressure (ICP) and hypotension have long been shown to lead to worse outcomes in the severe traumatic brain injury (TBI) population. Adequate sedation is a fundamental principle in TBI care, and ketamine is an attractive option for sedation since it does not commonly cause systemic hypotension, whereas most other sedative medications do. We evaluated the effects of ketamine boluses on both ICP and cerebral perfusion pressure (CPP) in patients with severe TBI and refractory ICP. Methods We conducted a retrospective review of all patients admitted to the neurointensive care unit at a single tertiary referral center who had a severe traumatic brain injury with indwelling intracranial pressure monitors. We identified those patients with refractory intracranial pressure who received boluses of ketamine. We defined refractory as any sustained ICP greater than 20 mmHg after the patient was adequately sedated, serum Na was at goal, and CO2 was maintained between 35 and 40 mmHg. The primary outcome was a reduction in ICP with a subsequent increase in CPP. Results The patient cohort consisted of 44 patients with a median age of 30 years and a median presenting Glasgow Coma Scale (GCS) of 5. The median reduction in ICP after administration of a ketamine bolus was −3.5 mmHg (IQR −9 to +1), and the postketamine ICP was significantly different from baseline (p < 0.001). Ketamine boluses led to an increase in CPP by 2 mmHg (IQR −5 to +12), which was also significantly different from baseline (p < 0.001). Conclusion In this single-institution study of patients with severe traumatic brain injury, ketamine boluses were associated with a reduction in ICP and an increase in CPP. This was a retrospective review of 43 patients and is therefore limited in nature, but further randomized controlled trials should be performed to confirm the findings.
背景长期以来,颅内压(ICP)升高和低血压已被证明会导致严重创伤性脑损伤(TBI)人群的预后恶化。充分镇静是TBI护理的基本原则,氯胺酮是一种有吸引力的镇静选择,因为它通常不会引起全身性低血压,而大多数其他镇静药物都会引起全身性降压。我们评估了氯胺酮推注对严重TBI和难治性ICP患者的ICP和脑灌注压(CPP)的影响。方法我们对在一个三级转诊中心入住神经重症监护室的所有患者进行了回顾性审查,这些患者患有严重创伤性脑损伤,并使用了内置颅内压监测仪。我们确定了那些接受氯胺酮推注的难治性颅内压患者。我们将难治性定义为任何持续ICP大于20 患者充分镇静后mmHg,血清Na达到目标,CO2保持在35-40之间 mmHg。主要结果是ICP减少,随后CPP增加。结果患者队列包括44名患者,中位年龄为30岁,格拉斯哥昏迷量表(GCS)中位值为5。氯胺酮推注给药后ICP的中位降低为−3.5 mmHg(IQR−9至+1),氯胺酮后的ICP与基线有显著差异(p<0.001)。氯胺酮推注导致CPP增加2 mmHg(IQR−5至+12),与基线相比也有显著差异(p<0.001)。结论在这项针对严重颅脑损伤患者的单一机构研究中,氯胺酮推注与ICP降低和CPP增加有关。这是对43名患者的回顾性审查,因此在性质上是有限的,但应进行进一步的随机对照试验来证实这一发现。
{"title":"Ketamine Boluses Are Associated with a Reduction in Intracranial Pressure and an Increase in Cerebral Perfusion Pressure: A Retrospective Observational Study of Patients with Severe Traumatic Brain Injury","authors":"Bradley A Dengler, O. Karam, Colleen A Barthol, Aaron B. Chance, Laura E. Snider, Clare M. Mundy, M. Bounajem, W. C. Johnson, M. Maita, Paola M. Mendez-Gomez, A. Seifi, Shaheryar Hafeez","doi":"10.1155/2022/3834165","DOIUrl":"https://doi.org/10.1155/2022/3834165","url":null,"abstract":"Background Increased intracranial pressure (ICP) and hypotension have long been shown to lead to worse outcomes in the severe traumatic brain injury (TBI) population. Adequate sedation is a fundamental principle in TBI care, and ketamine is an attractive option for sedation since it does not commonly cause systemic hypotension, whereas most other sedative medications do. We evaluated the effects of ketamine boluses on both ICP and cerebral perfusion pressure (CPP) in patients with severe TBI and refractory ICP. Methods We conducted a retrospective review of all patients admitted to the neurointensive care unit at a single tertiary referral center who had a severe traumatic brain injury with indwelling intracranial pressure monitors. We identified those patients with refractory intracranial pressure who received boluses of ketamine. We defined refractory as any sustained ICP greater than 20 mmHg after the patient was adequately sedated, serum Na was at goal, and CO2 was maintained between 35 and 40 mmHg. The primary outcome was a reduction in ICP with a subsequent increase in CPP. Results The patient cohort consisted of 44 patients with a median age of 30 years and a median presenting Glasgow Coma Scale (GCS) of 5. The median reduction in ICP after administration of a ketamine bolus was −3.5 mmHg (IQR −9 to +1), and the postketamine ICP was significantly different from baseline (p < 0.001). Ketamine boluses led to an increase in CPP by 2 mmHg (IQR −5 to +12), which was also significantly different from baseline (p < 0.001). Conclusion In this single-institution study of patients with severe traumatic brain injury, ketamine boluses were associated with a reduction in ICP and an increase in CPP. This was a retrospective review of 43 patients and is therefore limited in nature, but further randomized controlled trials should be performed to confirm the findings.","PeriodicalId":46583,"journal":{"name":"Critical Care Research and Practice","volume":" ","pages":""},"PeriodicalIF":1.7,"publicationDate":"2022-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47374917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Statin Use and Mortality among Patients Hospitalized with Sepsis: A Retrospective Cohort Study within Southern California, 2008–2018 脓毒症住院患者他汀类药物的使用和死亡率:2008-2018年南加州的回顾性队列研究
IF 1.7 Q3 CRITICAL CARE MEDICINE Pub Date : 2022-05-06 DOI: 10.1155/2022/7127531
B. Liang, Su-Jau T Yang, K. Wei, A. S. Yu, Brendan J Kim, M. Gould, J. Sim
Background Despite early goal-directed therapy, sepsis mortality remains high. Statins exhibit pleiotropic effects. Objective We sought to compare mortality outcomes among statin users versus nonusers who were hospitalized with sepsis. Methods Retrospective cohort study of patients (age ≥18 years) during 1/1/2008–9/30/2018. Mortality was compared between statin users and nonusers and within statin users (hydrophilic versus lipophilic, fungal versus synthetic derivation, and individual statins head-to-head). Multivariable Cox regression models were used to estimate hazard ratios (HR) for 30-day and 90-day mortality. Inverse probability treatment weighting (IPTW) analysis was performed to account for indication bias. Results Among 128,161 sepsis patients, 34,088 (26.6%) were prescribed statin drugs prior to admission. Statin users compared to nonusers had a 30-day and 90-day mortality HR (95% CI) of 0.80 (0.77–0.83) and 0.79 (0.77–0.81), respectively. Synthetic derived statin users compared to fungal derived users had a 30- and 90-day mortality HR (95% CI) of 0.86 (0.81–0.91) and 0.85 (0.81–0.89), respectively. Hydrophilic statin users compared to lipophilic users had a 30-day and 90-day mortality HR (95% CI) of 0.90 (0.81–1.01) and 0.86 (0.78–0.94), respectively. Compared to simvastatin, 30-day mortality HRs (95% CI) were 0.85 (0.66–1.10), 0.87 (0.82–0.92), 0.87 (0.76–0.98), and 1.22 (1.10–1.36) for rosuvastatin, atorvastatin, pravastatin, and lovastatin, respectively. Conclusion Statin use was associated with lower mortality in patients hospitalized with sepsis. Hydrophilic and synthetic statins were associated with better outcomes than lipophilic and fungal-based preparations.
背景尽管有早期的目标导向治疗,败血症的死亡率仍然很高。他汀类药物具有多效性作用。目的我们试图比较他汀类药物使用者和非使用者因败血症住院的死亡率。方法对2008年1月1日至2018年9月30日期间年龄≥18岁的患者进行回顾性队列研究。比较他汀类药物使用者和非使用者之间以及他汀类药物使用者内部的死亡率(亲水性与亲脂性、真菌性与合成衍生物以及单个他汀类药物的死亡率)。使用多变量Cox回归模型来估计30天和90天死亡率的危险比(HR)。进行反向概率治疗加权(IPTW)分析,以说明适应症偏倚。结果128161例败血症患者中,34088例(26.6%)在入院前服用他汀类药物。他汀类药物使用者与非使用者相比,30天和90天的死亡率HR(95%CI)分别为0.80(0.77-883)和0.79(0.77-881)。合成来源的他汀类药物使用者与真菌来源的使用者相比,30天和90天的死亡率HR(95%CI)分别为0.86(0.81-0.91)和0.85(0.81-0.89)。与亲脂性使用者相比,亲水性他汀类药物使用者的30天和90天死亡率HR(95%CI)分别为0.90(0.81–1.01)和0.86(0.78–0.94)。与辛伐他汀相比,瑞舒伐他汀、阿托伐他汀、普伐他汀和洛伐他汀的30天死亡率HR(95%CI)分别为0.85(0.66–1.10)、0.87(0.82–0.92)、0.87%(0.76–0.98)和1.22(1.10–1.36)。结论使用他汀类药物可降低败血症住院患者的死亡率。亲水性和合成他汀类药物比亲脂性和真菌制剂具有更好的疗效。
{"title":"Statin Use and Mortality among Patients Hospitalized with Sepsis: A Retrospective Cohort Study within Southern California, 2008–2018","authors":"B. Liang, Su-Jau T Yang, K. Wei, A. S. Yu, Brendan J Kim, M. Gould, J. Sim","doi":"10.1155/2022/7127531","DOIUrl":"https://doi.org/10.1155/2022/7127531","url":null,"abstract":"Background Despite early goal-directed therapy, sepsis mortality remains high. Statins exhibit pleiotropic effects. Objective We sought to compare mortality outcomes among statin users versus nonusers who were hospitalized with sepsis. Methods Retrospective cohort study of patients (age ≥18 years) during 1/1/2008–9/30/2018. Mortality was compared between statin users and nonusers and within statin users (hydrophilic versus lipophilic, fungal versus synthetic derivation, and individual statins head-to-head). Multivariable Cox regression models were used to estimate hazard ratios (HR) for 30-day and 90-day mortality. Inverse probability treatment weighting (IPTW) analysis was performed to account for indication bias. Results Among 128,161 sepsis patients, 34,088 (26.6%) were prescribed statin drugs prior to admission. Statin users compared to nonusers had a 30-day and 90-day mortality HR (95% CI) of 0.80 (0.77–0.83) and 0.79 (0.77–0.81), respectively. Synthetic derived statin users compared to fungal derived users had a 30- and 90-day mortality HR (95% CI) of 0.86 (0.81–0.91) and 0.85 (0.81–0.89), respectively. Hydrophilic statin users compared to lipophilic users had a 30-day and 90-day mortality HR (95% CI) of 0.90 (0.81–1.01) and 0.86 (0.78–0.94), respectively. Compared to simvastatin, 30-day mortality HRs (95% CI) were 0.85 (0.66–1.10), 0.87 (0.82–0.92), 0.87 (0.76–0.98), and 1.22 (1.10–1.36) for rosuvastatin, atorvastatin, pravastatin, and lovastatin, respectively. Conclusion Statin use was associated with lower mortality in patients hospitalized with sepsis. Hydrophilic and synthetic statins were associated with better outcomes than lipophilic and fungal-based preparations.","PeriodicalId":46583,"journal":{"name":"Critical Care Research and Practice","volume":" ","pages":""},"PeriodicalIF":1.7,"publicationDate":"2022-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49495119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Critical Care Research and Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1